<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Malgun Gothic";
panose-1:2 11 5 3 2 0 0 2 0 4;}
@font-face
{font-family:"\@Malgun Gothic";}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style>
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal">Dear Jacqueline, <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Your apology has been noted. <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Thank you.<o:p></o:p></p>
<p class="MsoNormal">Kind regards, <o:p></o:p></p>
<p class="MsoNormal">Claudia Ruiz<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>From:</b> lac-discuss-en [mailto:lac-discuss-en-bounces@atlarge-lists.icann.org]
<b>On Behalf Of </b>Jacqueline Morris<br>
<b>Sent:</b> Monday, April 16, 2018 5:02 PM<br>
<b>To:</b> Maritza Y. Aguero Minano <myaguero@msn.com><br>
<b>Cc:</b> lac-discuss-en@icann.org<br>
<b>Subject:</b> Re: [lac-discuss-en] RV: Gentle reminder - Meeting Invitation: LACRALO Monthly Call on Monday, 16 April 2018 at 23:00 UTC<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal">Sorry, marking exam papers and cannot attend.<o:p></o:p></p>
<div>
<p class="MsoNormal">Jacqueline<o:p></o:p></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div>
<p class="MsoNormal">On Mon, 16 Apr 2018, 7:12 PM Maritza Y. Aguero Minano, <<a href="mailto:myaguero@msn.com">myaguero@msn.com</a>> wrote:<o:p></o:p></p>
</div>
<blockquote style="border:none;border-left:solid #CCCCCC 1.0pt;padding:0in 0in 0in 6.0pt;margin-left:4.8pt;margin-right:0in">
<p class="MsoNormal"><br>
[[--Translated text (es -> en)--]]<br>
[[--This message had format issues and was not translated properly--]]<br>
<br>
<br>
Subject: RV: Gentle reminder - Meeting Invitation: LACRALO<br>
Monthly Call on Monday, 16 April 2018 at 23:00 UTC<br>
Desde:"Maritza Y. Aguero Minano" <<a href="mailto:myaguero@msn.com" target="_blank">myaguero@msn.com</a>><br>
<br>
<br>
Dear,<br>
<br>
to connect directly to the call, click here:<br>
<br>
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__mytrials.webex.com_mytrials_onstage_g.php-3FMTID-3De174bc278e560e89a327960f33fa01938&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=-ksL_1Aq4etY_VPiVa2Das9HczDeT_9hm1uLwDBPjJU&e=" target="_blank">https://mytrials.webex.com/mytrials/onstage/g.php?MTID=e174bc278e560e89a327960f33fa01938[mytrials.webex.com]</a><br>
Regards,<br>
From: Maritza Y. Aguero Minano <<a href="mailto:myaguero@msn.com" target="_blank">myaguero@msn.com</a>> Sent: Friday, April 13, 2018 03:29 pmTo: LACRALO discussion list Subject: Gentle reminder - Meeting Invitation: LACRALO Monthly Call on Monday, 16 April
2018 at 23:00 UTC<br>
<br>
<DNT> <br>
<br>
Dear all,<br>
<br>
This is a friendly reminder about the LACRALO monthly call and new instructions of participation.<br>
<br>
Regards,<br>
<br>
Maritza<br>
<br>
<DNT> <br>
<br>
De: lac-discuss-en <<a href="mailto:lac-discuss-en-bounces@atlarge-lists.icann.org" target="_blank">lac-discuss-en-bounces@atlarge-lists.icann.org</a>> en nombre de ICANN At-Large Staff <<a href="mailto:staff@atlarge.icann.org" target="_blank">staff@atlarge.icann.org</a>>
Enviado: martes, 10 de abril de 2018 03:56 p. m. Para: <a href="mailto:lac-discuss-en@atlarge-lists.icann.org" target="_blank">
lac-discuss-en@atlarge-lists.icann.org</a> Asunto: [lac-discuss-en] Meeting Invitation: LACRALO Monthly Call on Monday, 16 April 2018 at 23:00 UTC
<br>
<br>
If you require a dial-out please contact At-Large staff at <a href="mailto:staff@atlarge.icann.org" target="_blank">
staff@atlarge.icann.org</a> with your preferred number. Also find attached, Webex instructions.<br>
<br>
Dear All, <br>
<br>
The next LACRALO Monthly Call is scheduled for Monday, 16 April 2018 at 23:00 UTC. <br>
<br>
Spanish, French and Portuguese interpretations will be provided. <br>
<br>
For other times: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__tinyurl.com_y9d38yu3&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=S8L2XCogqXeoTdeYWBW7kW53Akl1sWYrmnL3kSoXmGg&e=" target="_blank">
https://tinyurl.com/y9d38yu3[tinyurl.com]</a> <br>
<br>
The agenda and call details can be found at: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_x_5QEFBQ&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=ccun__CRaiYZ8mQEg5z2yG8q-eAIgyIfTvL1-rI-wyM&e=" target="_blank">
https://community.icann.org/x/5QEFBQ[community.icann.org]</a> <br>
<br>
Wiki workspace: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__community.icann.org_x_NJQi&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=xgU45GT_APXaXOQPHCNOg6oWzUDXo_FQIsT_vaKYhqI&e=" target="_blank">
https://community.icann.org/x/NJQi[community.icann.org]</a> <br>
<br>
ADIGO Conference Bridge: <br>
English Conference ID = 1638 <br>
Spanish Conference ID = 1738 <br>
Portuguese Conference ID = 5393 <br>
French Conference ID = 1838 <br>
<br>
Toll-free access number (US and Canada): 800 550 6865 <br>
<br>
Other toll-free numbers: <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__adigo.com_icann_-255Badigo.com-255D&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=ci7ysGZ3ytN8dOI2gEMC87nwyt-BAggB_kPOdKc_qO8&e=" target="_blank">
http://adigo.com/icann/[adigo.com][adigo.com]</a> <br>
<br>
New Connection Information <br>
New Web conference tool: Webex <br>
Please join the meeting room here: 1. Click here[<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mytrials.webex.com&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=tJQ4ixUK1FWCQbaXUDFkH7I8U49PUk6yONDJMWzcqgc&e=" target="_blank">mytrials.webex.com[mytrials.webex.com]</a>]
to join the online event. Or copy and paste the following link to a browser: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__mytrials.webex.com_mytrials_onstage_g.php-3FMTID-3De174bc278e560e89a327960f33fa01938&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=-ksL_1Aq4etY_VPiVa2Das9HczDeT_9hm1uLwDBPjJU&e=" target="_blank">https://mytrials.webex.com/mytrials/onstage/g.php?MTID=e174bc278e560e89a327960f33fa01938[mytrials.webex.com]</a>
2. Click "Join Now". <br>
Audio connection: <br>
It’s possible to connect via Webex VoIP, but audio quality cannot be guaranteed. We recommend you connect to the audio bridge with your telephone.
<br>
To receive a call back, provide your phone number when you join the event, or call the number below and enter the access code. USA Toll: 1-240-454-0879 Global call-in numbers:
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__mytrials.webex.com_mytrials_globalcallin.php-3FserviceType&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=fdPFXTG53iLgaah1EU5UXIMP2vUPuNaNOIqAzDwIf30&e=" target="_blank">
https://mytrials.webex.com/mytrials/globalcallin.php?serviceType[mytrials.webex.com]</a><span style="font-family:"Malgun Gothic",sans-serif">㷬</span>&ED<span style="font-family:"Malgun Gothic",sans-serif">㵦</span>2226532&tollFreeϐ[<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__mytrials.webex.com&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=tJQ4ixUK1FWCQbaXUDFkH7I8U49PUk6yONDJMWzcqgc&e=" target="_blank">mytrials.webex.com[mytrials.webex.com]</a>]
Access code: 924 414 858 <br>
<br>
<br>
Thank you. <br>
Kind Regards, <br>
<br>
ICANN Policy Staff in support of the At-Large Community <br>
E-mail: <a href="mailto:staff@atlarge.icann.org" target="_blank">staff@atlarge.icann.org</a> <br>
Website: <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__atlarge.icann.org&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=ej5SWxuo-RFB5MXiem4DnfVuvIVoUVJRuzK6QOWmXWM&e=" target="_blank">
atlarge.icann.org[atlarge.icann.org]</a> <br>
Facebook: <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__facebook.com_icannatlarge&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=xdqeCGMIskzmQLFQL3NBZdh6BfHOyYb7d_GuKkDkc0g&e=" target="_blank">
facebook.com/icannatlarge[facebook.com]</a> <br>
Twitter: @ICANNAtLarge <br>
<br>
<br>
<br>
<DNT></DNT> <br>
<br>
[[--Original text (es)<br>
Translated by transbot 2.18-2.04<br>
<a href="http://mm.icann.org/transbot_archive/73edb27bfb.html" target="_blank">http://mm.icann.org/transbot_archive/73edb27bfb.html</a><br>
--]]<br>
_______________________________________________<br>
lac-discuss-en mailing list<br>
<a href="mailto:lac-discuss-en@atlarge-lists.icann.org" target="_blank">lac-discuss-en@atlarge-lists.icann.org</a><br>
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__atlarge-2Dlists.icann.org_mailman_listinfo_lac-2Ddiscuss-2Den&d=DwMFaQ&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=ds9md1zoepmwqw2nfk-Vs9ssxn1I3jPs97ekKkctEkM&m=7jCfpTxhiq2peUbpry6koqcLKXemC6Xb47FHvl8Vc_U&s=P_xGT8TX7jLmK7eQxBOZn_0jg4ORjrw33PTe7VSIB6Q&e=" target="_blank">https://atlarge-lists.icann.org/mailman/listinfo/lac-discuss-en[atlarge-lists.icann.org]</a><o:p></o:p></p>
</blockquote>
</div>
</div>
</body>
</html>